Company & Sponsor Intelligence

Wayne State University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting1

Completed3

Countries1

Therapeutic footprint

epilepsyother_neurologypain_neuropathyparkinsonsstrokesubstance_use

Indexed studies

NCT03391661University of Michigan / Wayne State Chronic Pain Study
pain_neuropathy · United StatesNA

NCT01975194Rosuvastatin in African Americans With Cerebrovascular Disease
stroke · United StatesPHASE4

NCT04920864rTMS, Stress and Opioid Use Disorder
substance_use · United StatesNA

NCT03914599Protective Genetic Factors Against Neurological Diseases
other_neurology · United StatesCOMPLETED

NCT03858270Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
parkinsons · United StatesPHASE3

NCT04986683Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
epilepsy · United StatesNA

NCT01959217Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse
substance_use · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →